On the other hand, Bmi-1 silencing was reported to promote apoptosis in NPC cells, thereby sensitizing them to chemotherapeutic and radiotherapeutic treatments [24–27]. The gene discussed is BMI1; the disease is nasopharyngeal carcinoma.